a market capitalization of just under 3 billion Swiss Francs ($2.78 billion), some larger players, such as Johnson & Johnson (JNJ), may be interested, according to analysts. Such a move would enable cash-rich pharmaceutical firms to enter a market that...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Dental Implants 2Q Earnings Seen Weak After Biomet 3i Data
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account